Skip to main content
logo
ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
12.79
+0.06 (0.47%)
At close: Nov 9, 2026, 4:00 PM EST
12.64
-0.15 (-1.15%)
After-hours: Nov 9, 2026, 7:35 PM EST

ADMA Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,8384,3414,0541,021857276
Market Cap Growth
-22.43%7.08%296.93%19.17%210.44%49.75%
Enterprise Value
2,9164,3634,0791,100975343
Last Close Price
12.7918.2417.154.523.881.41

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
16.5929.5520.51---
Forward PE
15.7322.2425.2836.16--
PS Ratio
5.478.519.513.965.563.41
PB Ratio
6.509.1011.627.555.641.96
P/TBV Ratio
6.539.1811.757.795.812.03
P/FCF Ratio
21.35156.0436.71253.51--
P/OCF Ratio
20.1586.1434.16116.07--
PEG Ratio
-1.371.20---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.628.559.564.266.334.24
EV/EBITDA Ratio
12.1121.8627.7435.88--
EV/EBIT Ratio
12.5022.7929.3549.27--
EV/FCF Ratio
21.94156.8236.93273.07--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.460.170.241.051.020.73
Debt / EBITDA Ratio
0.840.400.554.28--
Debt / FCF Ratio
1.532.870.7435.10--
Net Debt / Equity Ratio
0.18-0.02-0.060.670.450.37
Net Debt / EBITDA Ratio
0.33-0.04-0.142.94-2.11-0.99
Net Debt / FCF Ratio
0.59-0.28-0.1922.35-0.92-0.41
Asset Turnover
0.800.921.040.760.490.34
Inventory Turnover
0.711.151.211.010.830.77
Quick Ratio
3.083.542.761.582.602.62
Current Ratio
6.046.715.975.166.896.87
Return on Equity (ROE)
41.95%35.56%81.64%-19.67%-44.96%-62.46%
Return on Assets (ROA)
22.41%21.50%21.24%4.12%-7.88%-14.87%
Return on Invested Capital (ROIC)
36.54%38.62%50.24%10.03%-19.07%-35.65%
Return on Capital Employed (ROCE)
36.60%34.50%32.10%8.00%-12.70%-23.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
6.03%3.38%4.88%-2.77%-7.69%-25.95%
FCF Yield
4.68%0.64%2.72%0.39%-8.57%-45.59%
Buyback Yield / Dilution
1.28%-5.07%-4.07%-13.19%-41.77%-62.03%
SEC Filings: 10-K · 10-Q